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The human extracellular matrix glycoprotein
fibrillin-1 is the primary component of the 10- to 12-
nm-diameter microfibrils, which perform key struc-
tural and regulatory roles in connective tissues.
Relatively little is known about the molecular mecha-
nisms of fibrillin assembly into microfibrils. Studies
using recombinant fibrillin fragments indicate that
an interaction between the N- and C-terminal regions
drives head-to-tail assembly. Here, we present the
structure of a fibrillin N-terminal fragment comprising
the fibrillin unique N-terminal (FUN) and the first three
epidermal growth factor (EGF)-like domains (FUN-
EGF3). Two rod-like domain pairs are separated by
a short, flexible linker between the EGF1 and EGF2
domains. We also show that the binding site for the
C-terminal region spans multiple domains and
overlaps with a heparin interaction site. These data
suggest that heparan sulfate may sequester fibrillin
at the cell surface via FUN-EGF3 prior to aggregation
of the C terminus, thereby regulating microfibril
assembly.
INTRODUCTION
Fibrillins are the primary constituents of the 10- to 12-nm-diam-
eter microfibrils in the extracellular matrix (ECM) of many elastic
and non-elastic connective tissues. In elastic tissues such as the
lamellae of blood vessels, the skin, and the lungs, they are pre-
sent in elastic fibers in which they form a scaffold around an
amorphous elastin polymer (Sakai et al., 1986). Fibrillin microfi-
brils are also found in elastin-free assemblies in nonelastic tis-
sues such as the ciliary zonules of the eye and the kidney glomer-
ulus. In addition to performing structural roles, fibrillin microfibrils
contribute to the functional regulation of the ECM. They interact
with cells via integrins (Pfaff et al., 1996) and sequester growth
factors, notably latent transforming growth factor-b (TGF-b),
through interactions of fibrillin with the latent TGF-b-binding pro-
teins (LTBPs) (Ono et al., 2009) and the prodomains of several
bone morphogenetic proteins (BMPs) (Sengle et al., 2008).SThe importance of fibrillin microfibrils is highlighted by the
spectrum of acquired and inherited connective tissue disorders
associated with elastic fibers. For example, defects have been
identified in patients with pulmonary emphysema, aneurysms,
and pelvic organ prolapse (Yanagisawa andDavis, 2010).Marfan
syndrome (MFS) and congenital contractural arachnodactyly
were the first diseases to be linked to the human FBN1 and
FBN2 genes, respectively, which encode the fibrillin-1 and fibril-
lin-2 isoforms (Lee et al., 1991). More recently, a number of so-
called fibrillinopathies have been identified and characterized,
including stiff skin syndrome (Loeys et al., 2010), Weill-Marche-
sani syndrome (Faivre et al., 2003), and the acromelic dysplasias
(Le Goff et al., 2011).
Fibrillins have a modular organization that is conserved from
jellyfish to humans (Robertson et al., 2011). Their structures are
dominated by calcium-binding epidermal growth factor-like
(cbEGF) domains, of which there are 43 in human fibrillin-1
(Figure 1A). Arrays of cbEGF domains are interrupted by TGF-
b-binding protein-like (TB) and hybrid (hyb) domains. In addi-
tion, there are unique N- and C-terminal regions that are
processed by the protease furin (Kettle et al., 2000; Lo¨nnqvist
et al., 1998; Reinhardt et al., 2000). High-resolution structures
of the major domain types have been determined with the use
of nuclear magnetic resonance (NMR) spectroscopy and
X-ray crystallography (Downing et al., 1996; Jensen et al.,
2009; Yuan et al., 1997). In addition, fibrillin fragment structures
show the architecture of the interdomain interfaces, which is
important for understanding the conformation of the full-length
molecule. There are presently no high-resolution structures of
the N- and C-terminal regions, including the fibrillin unique
N-terminal (FUN) domain, the unique C-terminal region, and
the C-terminal propeptide.
Although there is a large body of work on intact microfibrils,
isolated fibrillin molecules, and recombinant fragments, many
molecular details regarding the assembly process and structural
organization of microfibrils are still lacking. Microfibrils extracted
from tissue have a periodic beaded filament structure, with an
average of 56 nm repeat distance between the beads (Keene
et al., 1991; Kielty et al., 1991). Because purified fibrillin mole-
cules have a length of150 nm (Sakai et al., 1991), two different
models have been proposed to explain the observed periodicity
of the beads. In the first model, fibrillin molecules adopt a linear
conformation and are staggered in microfibrils (Kuo et al., 2007;tructure 21, 1743–1756, October 8, 2013 ª2013 The Authors 1743
Figure 1. Fibrillin Domain Organization and
N-C-Terminal Interaction
(A) Domain structure of human fibrillin-1. Arrows
indicate furin cleavage sites near the N- and C-
termini: immediately preceding the fibrillin unique
N-terminal domain and in the unique C-terminal
region.
(B) Pull-down assay: cbEGF41-43 was immobi-
lized on streptavidin-coated magnetic beads and
used to pull down His-tagged FUN-EGF3 from
solution.
(C) Binding was assessed by western blotting with
an anti-RGS-His antibody. A separate blot with
streptavidin-HRP confirmed the presence of im-
mobilized proteins (Figure S1). The strong band at
17 kDa (arrow) in the boxed lane demonstrates
the interaction between FUN-EGF3 and cbEGF41-
43; a minor species at 30 kDa (asterisk) is
occasionally observed. Binding of the negative
control fragments fibrillin cbEGF32-34 (immobi-
lized) and Jagged-1 DSL-EGF3 (soluble) to FUN-
EGF3 and cbEGF41-43, respectively, was much
weaker than that observed for the true interaction
partners.
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Fibrillin N-Terminal Structure and InteractionsLee et al., 2004), whereas in the second, fibrillin monomers are
folded (Baldock et al., 2006).
A common feature of all models of microfibril structure is the
colocalization of fibrillin N- and C-terminal regions. This was first
shown by labeling microfibrils with antibodies raised against
recombinant fibrillin fragments (Reinhardt et al., 1996). Subse-
quently, an interaction between N- and C-terminal fibrillin
fragments was demonstrated in vitro (Lin et al., 2002; Marson
et al., 2005). The minimal interacting regions of human
fibrillin-1 were later localized to the FUN and three non-calcium-
binding EGF-like domains (FUN-EGF3) at theN-terminus (El-Hal-
lous et al., 2007) and last three cbEGF domains (cbEGF41-43) at
the C terminus (Hubmacher et al., 2008). Multimerization of the C
terminus into bead-like structures was also found to enhance its
binding to the N-terminus (Hubmacher et al., 2008). It has been
proposed that the N-C-terminal interaction is an important step
in the microfibril assembly pathway, mediating end-to-end
assembly of fibrillin monomers. The N-terminal region of fibrillin
also interacts with amultitude of other ECMmolecules, including
heparan sulfate (HS), which may regulate microfibril assembly
(Cain et al., 2005; Tiedemann et al., 2001). In addition, the1744 Structure 21, 1743–1756, October 8, 2013 ª2013 The AuthorsFUN-EGF3 region forms part of the
binding sites for two BMP prodomains
(Sengle et al., 2008; Sengle et al., 2011)
and the LTBPs (Ono et al., 2009).
Here, we present the solution structure
of the FUN-EGF3 region of human
fibrillin-1. We show that it comprises
two domain pairs connected by a flexible
linker, and reveal the structure of the FUN
domain. Furthermore, we demonstrate
that multiple domains in FUN-EGF3 con-
tribute to its binding to the cbEGF41-43
region. Using structure-informed muta-
genesis, we show that a loop in the FUNdomain and the flexible EGF1-EGF2 linker form part of the
binding site, which overlaps with a heparin interaction site. Our
data provide important insights into interactions involved in
fibrillin microfibril assembly.
RESULTS
Interaction of N- and C-Terminal Fibrillin-1 Fragments
An interaction between recombinant fragments corresponding
to the FUN-EGF3 (residues R45–E178) and cbEGF41-43 (resi-
dues D2567–V2687) regions of human fibrillin-1 was confirmed
using a pull-down assay prior to structure determination of
FUN-EGF3. These fragments were produced using an estab-
lished bacterial expression and in vitro refolding system (Knott
et al., 1996). Low solubility of the cbEGF41-43 fragment at pH
7.4 necessitated its immobilization on magnetic beads using
the streptavidin-biotin interaction. Immobilized, site-specifically
biotinylated cbEGF41-43 with a C-terminal BirA tag was used
to pull down FUN-EGF3 from solution (Figures 1B and 1C). Bind-
ing specificity was demonstrated using unrelated control frag-
ments with sizes and structures similar to those of FUN-EGF3
Table 1. NMR Structure Calculation Statistics
FUN-EGF3 (R45–E178) FUN-EGF1 (A53–C111) EGF2-EGF3 (C119–E178)
NOE-derived distance restraints
Total 2,599 1,559 1,040
Intraresidue 890 516 374
Interresidue 1,434 893 541
Sequential (j i-j j = 1) 571 340 231
Short-range (j i-j j < 5) 231 147 84
Long-range (j i-j jR 5) 632 406 226
Ambiguous 275 150 125
Hydrogen bond restraints 30 18 12
Dihedral angle restraints
Total 137 69 68
4 73 39 34
c 64 30 34
RDCs
1DNH 54 28 26
Total number of restraints 2,820 1,674 1,146
Restraint violations
Distance restraint violations > 0.5 A˚ 0 0 0
Dihedral angle violations > 5 0 0 0
Rmsd from experimental restraints
Distance restraints (A˚) 0.024 ± 0.001 0.025 ± 0.001 0.024 ± 0.003
Dihedral angle restraints () 0.338 ± 0.109 0.194 ± 0.141 0.408 ± 0.171
RDC restraints (Hz) 0.822 ± 0.074 0.755 ± 0.078 0.884 ± 0.110
Rmsd from idealized geometry
Bonds (A˚) 0.004 ± 0.000 0.004 ± 0.000 0.003 ± 0.000
Angles () 0.513 ± 0.016 0.552 ± 0.016 0.501 ± 0.019
Impropers () 0.365 ± 0.007 0.417 ± 0.016 0.337 ± 0.015
Ramachandran plot
Residues in most favored regions (%) 80.5 81.8 81.9
Residues in additional allowed regions (%) 16.0 18.1 13.4
Residues in generously allowed regions (%) 1.6 0.1 1.7
Residues in disallowed regions (%) 1.9 0.0 3.0
Coordinate precision (rmsd; A˚)
Backbone N/A 0.586 ± 0.196 1.166 ± 0.288
Heavy atom N/A 0.916 ± 0.246 1.820 ± 0.305
Statistics are given for full-length FUN-EGF3 and separately for the two domain pairs. Quality statistics were calculated using Xplor-NIH. Restraint
violations and rmsd values are given as mean values per structure ± the SD. Ramachandran statistics were calculated using Procheck (Laskowski
et al., 1996). N/A, not applicable.
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of human Jagged-1 (Cordle et al., 2008a) in place of FUN-EGF3,
and the human fibrillin-1 cbEGF32-34 fragment instead of
cbEGF41-43. The observed binding to cbEGF41-43 indicated
that the refolded FUN-EGF3 fragment had native-like properties.
Structure Determination of FUN-EGF3 and Analysis of
Dynamics
NMR spectroscopy was used to solve the structure of FUN-
EGF3. The structure was determined by simulated annealing
from an extended template using 2,599 nuclear Overhauser
effect (NOE) and 137 f and c torsion angle restraints (Table 1).
Structures were refined using hydrogen bond restraints andSresidual dipolar couplings (RDCs). There were many NOEs
between residues in the FUN and EGF1 domains, as well
as between the EGF2 and EGF3 domains. However, no NOEs
between the FUN-EGF1 and EGF2-EGF3 domain pairs were
observed, which was reflected by the variability of their relative
orientation in the 20-structure ensemble (Figure 2A). This was
due to an unstructured seven-residue linker sequence between
the EGF1 and EGF2 domains (residues G112–H118; Figure 2B).
The N-terminal segment of the FUN domain (residues R45–A52)
was similarly poorly defined. The disordered character of these
regions was previously predicted from chemical shifts (Yadin
et al., 2012). Therefore, separate alignment tensors for the
RDC restraints were used for FUN-EGF1 and EGF2-EGF3 intructure 21, 1743–1756, October 8, 2013 ª2013 The Authors 1745
Figure 2. Final Structure Ensemble of
FUN-EGF3
(A) Twenty-structure ensemble of FUN-EGF3, with
structures aligned to the FUN-EGF1 region
(cartoon representation). Disulphides are shown
as sticks. The FUN and EGF1 domains are colored
lilac and green, respectively, and the EGF2–EGF3
region is colored white.
(B) Lowest-energy structure from the FUN-EGF3
ensemble, with the EGF1-EGF2 linker sequence
(G112–H118) in red.
(C and D) Backbone of the (C) FUN-EGF1 region,
showing residues 52–112, and (D) EGF2–EGF3
region, showing residues 118–178. Energy-
minimized average structures are shown below
the aligned ensembles.
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Fibrillin N-Terminal Structure and Interactionsrefinement; average structures for the two units were calculated
separately (Figures 2C and 2D).
A study of the backbone dynamics of FUN-EGF3 confirmed
the presence of the flexible EGF1-EGF2 linker and highlighted
other dynamic regions (Figure 3A). Residues in the linker had
lower heteronuclear NOE ratios comparedwith residues in struc-
tured regions, indicating increased mobility on the picosecond-
to-nanosecond timescale (Figure 3B). The experiment also
showed flexibility at the N terminus, as well as a loop in the
FUN domain (S61–A65) and the C-terminal portion of the EGF3
domain (C168–E176). The profile of heteronuclear NOE ratios
was consistent with the backbone root-mean-square deviation
(rmsd) values for members of the structure ensemble (Figure 3C).
In addition, the variability of the T1/T2 ratios across the backbone1746 Structure 21, 1743–1756, October 8, 2013 ª2013 The Authorsindicated that many residues, particularly
those in the EGF3 domain, exhibited
motion on slower timescales (Figure 3D).
In full-length fibrillin, EGF3 is likely to
form an interface with the hyb1 domain.
Several putative packing residues have
different chemical shifts in a four-domain
fragment comprising domains EGF2–
cbEGF1 (Robertson et al., 2013). Overall,
these results supported the structure and
identified considerable internal dynamics
on both fast and slow timescales.
Domain Structures
The FUN-EGF3 structure shows the fold
of the FUN domain, which was previ-
ously unknown (Figure 4A). With the
exception of the unstructured N-terminal
residues (R45–A52), the FUN domain
adopts a compact conformation, but
with little regular secondary structure. It
comprises two loops connected by
disulphide bonds, with an N-terminal
segment that packs in between. The
disulphide bond pairings of C59-C68
and C67-C80 (C1-C3 and C2-C4) were
initially determined dynamically in the
simulated annealing calculations andwere supported by NOEs between cysteine side-chain reso-
nances. The three EGF-like domains in the FUN-EGF3 fragment
have a canonical EGF-like fold, with a disulphide bond arrange-
ment of C1-C3, C2-C4, and C5-C6 (Bork et al., 1996; Figures
4B–4D). They all contain a b-hairpin motif, but the EGF1 domain
also has a third minor b strand. Despite little obvious sequence
identity between the FUN and EGF-like domains (Figure 4E),
their C-terminal segments are structurally similar (Figure 4F).
Instead of the b-hairpin structure of the EGF-like domain, the
FUN domain has a flexible loop. Unlike the EGF b-hairpin,
the loop in the FUN domain is not disulphide bonded to the
N-terminal segment of the domain. This may explain the differ-
ences in the dynamic behavior of the two domains and could
have functional significance.
Figure 3. Dynamics and Structure Precision
of FUN-EGF3
(A) Surface representation of a member of the
FUN-EGF3 structure ensemble, with dynamic
regions highlighted in red: N terminus (R45–A52;
star), FUN domain loop (S61–A66; square), EGF1-
EGF2 linker (G112–H118; circle), and C-terminal
loop of EGF3 (T169–E178; triangle).
(B) {1H}-15N heteronuclear NOE ratios plotted as a
function of residue number. Dynamic regions
highlighted in (A) are indicated by shapes. Asn/Gln
side-chain data are presented in Table S1.
(C) Backbone rmsd for each residue from the
energy-minimized average structures of FUN-
EGF1 (up to S115) and EGF2-EGF3 (from I116).
N-terminal residues with rmsd > 10 A˚ are omitted
for clarity.
(D) T1/T2 values plotted against residue number.
Errors in the {1H}-15N heteronuclear NOE ratios (B)
and T1/T2 (D) were estimated using 500 Monte
Carlo simulations, with the baseline noise as a
measure of peak height error, as described pre-
viously (Bruylants and Redfield, 2009).
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Interdomain interfaces within the FUN-EGF1 and EGF2-EGF3
domain pairs are well defined, but there is no observed inter-
face between the EGF1 and EGF2 domains. Buried surface
areas at the interfaces of the FUN-EGF1 and EGF2-EGF3 pairs,
calculated from the energy-minimized average structures, were
found to be 290 and 239 A˚2, respectively. The areas buried by
these interfaces are larger than those buried in a cbEGF-cbEGF
pair, but smaller than those of TB-cbEGF and hyb-cbEGF inter-
faces: 184 A˚2 for cbEGF32-cbEGF33 (Downing et al., 1996),
552 A˚2 for TB4-cbEGF23 (Lee et al., 2004), and 670 A˚2 for
hyb2-cbEGF10 (Jensen et al., 2009). The FUN-EGF1 interface
is formed by G70, W71, K72, L73, and I81 in the FUN domain,
and V82, P83, I84, and P97 in the EGF1 domain (Figure 5A).
Similarly, the EGF2-EGF3 interface is formed by G139, Y140,
and I141 in the EGF2 domain, analogous to the G-W-K motif
in the FUN domain, and the packing residues from EGF3 are
Q147, P148, V149, and P163, similar to the EGF1 domain (Fig-
ure 5B). EGF2 does not have an analog of L73 in the FUNStructure 21, 1743–1756,domain, accounting for the larger sur-
face area buried by the FUN-EGF1
interface.
Aligning the sequences of the FUN-
EGF1 and EGF2-EGF3 pairs highlights
the similar arrangement of packing resi-
dues (Figure 5C). Residues at equivalent
positions in the EGF1 and EGF2 domains
are absent, explaining the lack of an
interdomain interface. In addition, resi-
dues N57 and N125 from the FUN and
EGF2 domains, respectively, pack
against the aromatic rings of W71 and
Y140, and are likely to contribute to the
stability of the interdomain interfaces.
The NH2 side-chain groups of these two
residues are less mobile than surface-exposed side-chains (Table S1 available online), supporting their
roles in interdomain packing.
Interestingly, three missense mutations found in patients
with MFS result in substitutions of residues at the interdomain
interfaces: N57D (Chung et al., 2009) and W71R (Sakai et al.,
2006) in the FUN domain and P148S in the EGF3 domain
(Figure 5D; Stheneur et al., 2009). These substitutions could
disrupt interdomain interfaces, resulting in misfolding and
intracellular retention, as was previously observed for several
MFS mutations (Whiteman et al., 2007). Introduction of the
N57D and P148S substitutions into the FUN-EGF3 frag-
ment resulted in local misfolding of the FUN and EGF3
domains, respectively, whereas the W71R substitution caused
global misfolding (Table S2; Figure S2). Furthermore, intro-
duction of the N57D and W71R substitutions into a longer
N-terminal fragment resulted in partial retention of the pro-
tein by fibroblast cells (Figure S2). This may suggest a patho-
genic mechanism of functional haploinsufficiency for these
mutations.October 8, 2013 ª2013 The Authors 1747
Figure 4. Domain Structures in the FUN-
EGF3 Fragment
(A) The FUN domain comprises two loops (one of
which is flexible) linked by two disulphide bonds in
a 1-3, 2-4 pattern (C59-C68 and C67-C80).
(B) The EGF1 domain has a canonical 1-3, 2-4,
5-6 disulphide bond arrangement and a three-
stranded antiparallel b sheet.
(C and D) Structure of the EGF2 (C) and EGF3 (D)
domains, which contain a b-hairpin, is shown.
(E) Comparison of the FUN and EGF2 primary
structure. Sequences were aligned manually on
the basis of structural homology. Arrows represent
stretches of b-sheet-like secondary structure and
dotted lines indicate disulphide bonds.
(F) Backbone of the EGF2 domain (green) super-
imposed on the FUN domain (lilac), illustrating the
similarity of their C-terminal portions (dashed box).
The b-hairpin in EGF2 is indicated.
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Pairs
The Dali server (Holm and Rosenstro¨m, 2010) did not find any
structural homologs of the FUN-EGF1 domain pair, suggesting
that the FUNdomain has a novel fold. However, there are domain
pairs with homologous sequences at the N termini of human
LTBP-1L (long isoform) and LTBP-2 (Robertson et al., 2011), as
well as in the liver-specific von Willebrand factor C and EGF
domain-containing protein (VWCE/URG11) (Lian et al., 2006).
Sequence alignments show an identical arrangement of cyste-
ines and the presence of several of the key packing residues
from fibrillin-1 FUN-EGF1 in LTBP-1L (Figure 6A). Strikingly, a
conserved four-residue (63Y-N-A-Y66) motif in the flexible loop
of the fibrillin-1 FUN domain is missing from the LTBPs.
There are several homologs of the EGF2-EGF3 domain pair
with known structures: the EGF1-EGF2 pair in human hedgehog
interacting protein (HHIP) (Bishop et al., 2009), EGF2-EGF3 in
Wnt inhibitory factor-1 (WIF-1) (Malinauskas et al., 2011), and
EGF1-EGF2 in human Jagged-1 (Cordle et al., 2008a). Like the
fibrillin-1 EGF2-EGF3 pair, they all adopt a rod-like conforma-
tion, but there is variation in the twist and tilt angles and the
buried surface area (Figures 6B–6E). The G-F/Y/W motif in the
N-terminal EGF and the proline residue between C3 and C4 of
the C-terminal EGF domain are found in all four domain pairs,
but other packing residues differ (Figure 6F). The sequence
variation presumably reflects the different functional roles of
the EGF-domain-containing proteins.
Sequence Conservation
Sequence alignments of the FUN-EGF3 region from the three
human fibrillin isoforms and a variety of fibrillin-containing species
show a significant conservation across the evolutionary tree. The1748 Structure 21, 1743–1756, October 8, 2013 ª2013 The Authorsarrangement of cysteines is absolutely
conserved,asaremanyof thepacking res-
idues in fibrillin-1 (Figure 7). By contrast,
the flexible linker sequence between
EGF1 and EGF2 is longer in several
invertebrate species, particularly in the
red flour beetle Tribolium castaneum.Within the structured domains of FUN-EGF3, there are a number
of conserved residues that do not have an obviously structural
role. Interpretation of sequence conservation in terms of function
is not straightforward because of the large number of ECM com-
ponents that may interact with the fibrillin N-terminal domains.
However, fibrillin microfibrils are found in several lower metazoa,
such as jellyfish (Reber-Mu¨ller et al., 1995), supporting the uni-
versal role of fibrillins as microfibril-forming proteins. By contrast,
many potential interaction partners, including the LTBPs and
microfibril-associated glycoproteins (MAGPs), are not found in
all fibrillin-containing organisms (Robertson et al., 2011). Residues
conserved from humans to lower metazoa may be implicated in
theN-C-terminal interactionand therebyalsomicrofibril assembly.
Dissecting the Fibrillin N-C Interaction
Molecular details of the N-C interaction were investigated using
information from the FUN-EGF3 sequence and structure.
Attempts to use NMR tomap the binding surface of cbEGF41-43
on FUN-EGF3 were not successful. Peak intensities decreased
uniformly as cbEGF41-43 was added to 15N-labeled FUN-
EGF3 (data not shown), which may be due to the low solubility
of cbEGF41-43 noted above. Instead, a dissection approach
using smaller N-terminal fragments was used in the pull-down
assay with immobilized cbEGF41-43 (Figures 8A and 8B). The
domain pairs FUN-EGF1 and EGF2-EGF3 (containing the
EGF1-EGF2 linker sequence 113S-R-S-I-Q-H118, denoted
L-EGF2-EGF3) did not show appreciable binding to cbEGF41-
43. In contrast, the EGF1-EGF3 fragment did bind to
cbEGF41-43. Addition of the EGF1-EGF2 linker sequence to
the C terminus of FUN-EGF1 led to detectable binding, sug-
gesting that EGF1 in combination with the linker plays an
important role in the interaction.
Figure 5. Interdomain Interfaces in FUN-
EGF3
(A) Packing interactions between the FUN (lilac)
and EGF1 (green) domains, showing two views of
opposite faces. Residues involved in interdomain
packing are shown as spheres and are colored
according to domain. Packing residues were
identified using a 4 A˚ interatomic distance cutoff
as described previously (Jensen et al., 2009).
(B) EGF2-EGF3 packing interactions. Residues
from EGF2 and EGF3 involved in packing are
colored light green and green, respectively.
(C) Sequence alignment of the FUN-EGF1 and
EGF2-EGF3 regions. Cysteines and packing resi-
dues are colored yellow and red, respectively. The
dotted line delimits the domain boundaries.
(D) Residues at interdomain interfaces that are
substituted as a result of MFS-associated muta-
tions (N57D and W71R in the FUN domain and
P148S in EGF3). Further data for these mutations
are given in Figure S2 and Table S2.
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assay. Five conserved residues (R62, S88, N98, D131, and R159)
were individually substituted with alanine (Figure 8C). They were
chosen on the basis of their evolutionary conservation (Figure 7)
and surface exposure. None of these abolished the interaction
with cbEGF41-43, but R62A FUN-EGF3 showed reduced bind-
ing compared with wild-type FUN-EGF3 (Figure 8D and data
not shown). A mutant lacking the 63Y-N-A-Y66 motif in the FUN
domain showed reduced binding to cbEGF41-43. Replacement
of the 113S-R-S-I-Q117 linker motif with five glycines (G5) also
resulted in reduced binding (Figure 8D). Together, the fragment
and mutant results support a binding surface that spans at least
FUN-EGF1 and the EGF1-EGF2 linker region in FUN-EGF3.
EGF2 and EGF3 do not make a detectable contribution to
high-affinity binding.
Heparin Binding
An N-terminal fibrillin fragment encompassing the region from
the FUN domain to the EGF4 domain (FUN-EGF4) binds to
heparin (Cain et al., 2005; Tiedemann et al., 2001). Similarly,
FUN-EGF3 bound to a heparin column and was eluted on a
NaCl gradient (Figure 8E). Substitution of positively charged
residues had variable effects on heparin binding. R62A FUN-
EGF3 passed straight through the column, whereas R159A
FUN-EGF3 eluted at a lower NaCl concentration than the wild-Structure 21, 1743–1756,type protein. Deletion of the 63Y-N-A-Y66
motif only had a minor effect on heparin
binding, and the G5 mutant (lacking
R114) eluted earlier than the wild-type
(Figure 8F). These results indicate that
arginine residues, particularly R62 in the
FUN domain, are involved in the binding
of FUN-EGF3 to heparin.
DISCUSSION
Here, we present the structure of the
FUN-EGF3 region of human fibrillin-1,showing the novel fold of the FUN domain and architecture of
the interdomain interfaces. The structure provides insights into
the organization of the fibrillin N-terminal domains, which is
important for understanding the overall shape of fibrillin in micro-
fibrils. In addition, structure-informedmutagenesis of FUN-EGF3
enabled us to characterize its interaction with the three
C-terminal cbEGF domains of fibrillin, cbEGF41-43, and heparin.
This study adds to the set of high-resolution structures of fibril-
lin domain types and interdomain interfaces. Previous work
elucidated the structures of the major domain types in fibrillin,
i.e., the cbEGF (Downing et al., 1996), TB (Yuan et al., 1997),
and hyb domains (Jensen et al., 2009). However, the remaining
regions with unknown structures, such as the N terminus, are
some of the most functionally important. A previous study of
evolutionary conservation showed that the region encoded by
exon 2 of the FBN1 gene (P56–I81) is largely conserved, espe-
cially the spacing of cysteines and other residues shown here
to be involved in interdomain interactions (Piha-Gossack et al.,
2012). In the FUN-EGF3 structure, this region makes up most
of the structured ‘‘core’’ of the FUN domain. Furthermore, resi-
dues L53–G55, encoded by exon 1, form part of the core—a
feature that could not have been predicted from amino acid se-
quences. Although it is unique within fibrillin, the FUN domain
has homologs in the human proteins LTBP-1L/2 and VWCE,
which are also associated with a C-terminal EGF-like domain.October 8, 2013 ª2013 The Authors 1749
Figure 6. Homologs of the FUN-EGF1 and
EGF2-EGF3 Domain Pairs
(A) Sequence alignment of homologs of the FUN-
EGF1 domain pair in other proteins (LTBP-1L,
LTBP-2, and VWCE). The LTBPs lack the four-
residue sequence preceding the C-C motif.
(B–E) Packing residues in EGF-EGF domain pairs,
also showing the interdomain twist and tilt angles.
The backbone rmsd from the fibrillin-1 EGF2-
EGF3 pair, calculated using the Superpose server
(Maiti et al., 2004), is given for the three homologs.
(B) Fibrillin-1 EGF2-EGF3.
(C) Human hedgehog interacting protein (HHIP)
EGF1-EGF2 (PDB ID 3H0B).
(D) Wnt inhibitory factor-1 (WIF-1) EGF2-EGF3
(PDB ID 1IVO).
(E) Human Jagged-1 EGF1-EGF2 (PDB ID 2V2J).
(F) Sequence alignment of fibrillin-1, HHIP, WIF-1,
and Jagged EGF-EGF domain pairs. Packing
residues are colored red and indicated above
the sequences. Additional packing residues in
Jagged-1 are highlighted in blue.
Structure
Fibrillin N-Terminal Structure and InteractionsGiven the similarity of the C-terminal portions of the FUN and
EGF2 domains, it is possible that the FUN-EGF pair evolved
from an EGF-EGF domain pair.
Studying the structure and dynamics of fibrillin is important for
understanding microfibril organization. Previous high-resolution
structures indicated that fibrillin monomers adopt linear confor-
mations, consistent with staggered models of microfibril struc-
ture (Downing et al., 1996; Jensen et al., 2009; Lee et al.,
2004). Likewise, the EGF2-EGF3 domain pair has a rod-like
shape. However, the flexible linker between the EGF1 and
EGF2 domains is strikingly different from most other regions of
fibrillin. An earlier study showed that the linker between the
TB6 and cbEGF32 domains is also flexible (Yuan et al., 2002).
The TB6-cbEGF32 interface is less extensive than in other
TB-cbEGF pairs, as two key packing motifs are missing (Jensen
et al., 2005). Similarly, the EGF1 and EGF2 domains lack packing
residues found in the FUN-EGF1 and EGF2-EGF3 pairs (an1750 Structure 21, 1743–1756, October 8, 2013 ª2013 The Authorsaromatic residue between C5 and C6 in
EGF1, and the proline between C3 and
C4 in EGF2), as well as packing residues
in the interdomain linker. The flexibility of
the linker means that the orientation of
FUN-EGF1 relative to the rest of fibrillin
is likely to be variable. There are few
other candidates for flexible interdomain
regions, although it has been speculated
that the Pro-rich region could act as a
hinge (Pereira et al., 1993). Our structure
allows us to further improve the model
for fibrillin organization (Figure 9A).
Despite flexibility in the N-terminal region,
the overall linear shape of fibrillin ex-
cludes the possibility of N-C-terminal
interactions within the same molecule.
Structure-informed mutagenesis of
FUN-EGF3 provided insights into the
binding site for cbEGF41-43. A pull-down assay for the N-C interaction was established using the
immobilized cbEGF41-43 fragment. Multimerization of the
fibrillin C-terminal domains enhances their apparent affinity for
binding to the fibrillin N-terminal region (Hubmacher et al.,
2008). Thus, clustering of cbEGF41-43 (the minimal fragment
that binds to the N-terminal domains) on beads is likely to mimic
the in vivo situation. A comparison of the binding of FUN-EGF3 to
cbEGF41-43 with smaller N-terminal fragments demonstrated
that multiple domains contribute to the interaction. Furthermore,
the EGF1-EGF2 linker was shown to play an important role.
Flexibility of this region means that the two domain pairs could
potentially fold back to interact with the C terminus (Figure 9B).
In addition, the R62A substitution and deletion of the 63Y-N-
A-Y66 motif, which are both in the flexible loop of the FUN
domain, also resulted in reduced binding. Their involvement sug-
gests which face of FUN-EGF1 contributes to the interaction
(Figure 9C).
Figure 7. Sequence Alignments of the FUN-EGF3 Region
Sequences of the FUN-EGF3 region from a range of species were obtained from NCBI and Ensembl databases (Table S3) and aligned using ClustalOmega.
Residue numbers are given for human fibrillin-1. Cysteines and packing residues identified from the structure of fibrillin-1 FUN-EGF3 are colored yellow and red,
respectively. Residues in the EGF3 domain that pack against the hyb1 domain have not yet been well defined, but N156 and the G171-F172 motif (indicated by *)
are also highlighted in red, according to their similarity to packing residues at the FUN-EGF1 and EGF2-EGF3 interdomain interfaces and chemical-shift
differences from the EGF2-cbEGF1 fragment (Robertson et al., 2013). Packing motifs are present in sequences from all species shown, but not every residue is
fully conserved. Other conserved residues are colored blue; similar residues are shown in a lighter shade. Highlighted conserved residues are present in at least
one of the three species lacking LTBPs, fibulins, and MAGPs (sea squirt, red flour beetle, and sea anemone) (Robertson et al., 2011). Residues targeted here by
mutagenesis are indicated.
Structure
Fibrillin N-Terminal Structure and InteractionsWe also identified residues in FUN-EGF3 that contribute to
heparin binding. Previous work showed that MFS-associated
substitution T101A reduced the heparin-binding affinity of the
longer FUN-EGF4 fragment (Cain et al., 2005). T101 is partially
buried in the FUN-EGF3 structure, strongly suggesting that the
substitution had an indirect effect by perturbing protein folding.SOur results indicate that surface-accessible, positively charged
residues, particularly R62, contribute to heparin binding. The
overlap of the heparin and cbEGF41-43 binding sites suggests
that HS may regulate the N-C-terminal interaction. Indeed, the
addition of heparin or HS blocks microfibril assembly in cell cul-
ture, as does inhibition of HS synthesis (Tiedemann et al., 2001).tructure 21, 1743–1756, October 8, 2013 ª2013 The Authors 1751
Figure 8. Mapping the Binding Sites for cbEGF41-43 and Heparin on FUN-EGF3
(A) Pull-down assay using immobilized cbEGF41-43 with various N-terminal fragments (FUN-EGF3, EGF1-EGF3, FUN-EGF1, FUN-EGF1-L [L denotes with the
EGF1-EGF2 linker], and L-EGF2-EGF3). No significant binding was detected for FUN-EGF1 or L-EGF2-EGF3. See also Figure S1.
(B) Summary of results for pull-downs of shorter fragments.
(C) FUN-EGF3 structure showing residues targeted by site-directedmutagenesis. Five single residues were substitutedwith alanine (red), 63Y-N-A-Y66 in the FUN
domain (blue) was deleted, and 113S-R-S-I-Q117 in the EGF1-EGF2 linker (blue) was replaced with five glycines.
(legend continued on next page)
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Figure 9. Implications of the FUN-EGF3
Structure for Microfibril Structure and As-
sembly
(A) Fibrillin organization in microfibrils. Microfibrils
extracted from tissue have a ‘‘beads-on-a-string’’
appearance; the diameter and interbead dis-
tances are indicated. An elongated arrangement
of fibrillin monomers, each spanning two interbead
regions of the microfibril, is shown according to
the most recent version of the staggered model
(Kuo et al., 2007). Approximate dimensions are
given for three regions separated by the Pro-rich
and TB6 domains using the following lengths:
2.7 nm, 2.3 nm, 2.0 nm, and 2.1 nm for cbEGF, TB,
hyb, and non-calcium binding EGF-like domains,
respectively. Flexibility of interdomain linkers is
indicated by arrows.
(B) The flexibility of the EGF1-EGF2 linker
sequencemeans that the relative orientation of the
FUN-EGF1 and EGF2-EGF3 pairs is variable,
which may facilitate binding to cbEGF41-43.
(C) Surface representation of a FUN-EGF3 struc-
ture from the ensemble, showing the regions
involved in binding to cbEGF41-43, as well as
N164 (LTBP-4 binding). Multiple domains of
cbEGF41-43 (homology model based on
cbEGF32-33 structure) span the interacting re-
gions of FUN-EGF3.
(D) Hypothetical model for HS regulation of the fi-
brillin N-C-terminal interaction. Secreted fibrillin
monomers are sequestered on the cell surface by
HS through binding to FUN-EGF3 (1). Oligomeri-
zation of the C-terminal domains (2) creates a
high-affinity binding site that competes with HS for
binding to FUN-EGF3 (3).
Structure
Fibrillin N-Terminal Structure and InteractionsA plausible explanation for these effects is that HS sequesters
fibrillin monomers at the cell surface, preventing premature N-C
interactions. Subsequent oligomerization of the C-terminal
domains creates a high-affinity binding site for the N-terminal
domains, which competes with the binding of FUN-EGF3 to HS.(D) Pull-down assay with FUN-EGF3 mutants. R62A, YNAY, and G5 all show reduced binding relative to wild
although very similar quantities were added to the beads (‘‘protein only’’). Streptavidin-HRP blots confir
(Figure S1). Correct folding of the N-terminal fragments and the proteins containing mutations was shown b
(E) Elution profiles for binding of WT, R62A, and R159A FUN-EGF3 to a heparin column; A280 values are norma
bound to the column and eluted on a NaCl gradient (dashed line).
(F) Heparin elution profiles for YNAY and G5 FUN-EGF3.
Structure 21, 1743–1756,This results in regulated end-to-end as-
sembly of fibrillin aggregates (Figure 9D).
The FUN-EGF3 structure will allow the
binding sites of other elastic fiber mole-
cules on fibrillin to be mapped in detail.
The N164S residue substitution, which is
associated with dominant ectopia lentis,
perturbed binding of the FUN-EGF4 frag-
ment to LTBP-4 (Ono et al., 2009). Identi-
fying the location of this residue suggests
which face of the EGF3 domain forms the
binding site for LTBP-4 (Figure 9C).
In summary, we have determined the
structure of the functionally importantN-terminal domains of human fibrillin-1, which constitute the
minimal interaction site for the fibrillin C terminus. As well as
helping to identify regions involved in binding the C terminus
and heparin, this structure will be essential for future studies of
fibrillin interactions with elastic fiber molecules.-type (WT) and S88A (positive control) FUN-EGF3,
med the presence of cbEGF41-43 on the beads
y SDS-PAGE and NMR (Figure S3).
lized to the maximum for each trace. Proteins were
October 8, 2013 ª2013 The Authors 1753
Structure
Fibrillin N-Terminal Structure and InteractionsEXPERIMENTAL PROCEDURES
Cloning and Site-Directed Mutagenesis
Sequences encoding the FUN-EGF3 and cbEGF41-43 regions of human
fibrillin-1 were cloned into the pQE-30 vector (QIAGEN) for protein expression
in Escherichia coli as described previously (Knott et al., 1996). A modified
vector was used for constructs with C-terminal BirA tags (Cordle et al.,
2008b). Site-directed mutagenesis was performed using the QuikChange
Lightning mutagenesis kit (Agilent). The FUN-EGF3 (G5) mutant was cloned
using an overlapping PCR.
Protein Expression, Purification, Refolding, and Characterization
Protein expression, isotopic labeling, and purification protocols were similar to
those described previously (Cordle et al., 2008b; Knott et al., 1996; Yadin et al.,
2012). All proteins required the addition of 50% (v/v) glycerol to the refolding
mixture. Refolding of cbEGF41-43 was carried out at pH 9.0 to maintain
solubility. BirA-tagged proteins were biotinylated using an establishedmethod
(Cordle et al., 2008b). SDS-PAGE analysis of protein fragments is shown in
Figure S3. Heparin-binding experiments were performed using a HiTrap
Heparin column (GE Healthcare) on an A¨KTA system. Proteins were diluted
in buffer consisting of 20 mM Tris-HCl pH 7.4 and 150 mM NaCl before they
were loaded onto the column.
Pull-Down Protein-Protein Interaction Assay
Biotinylated cbEGF41-43 or the control protein cbEGF32-34 was immobilized
on M270 streptavidin-coated magnetic beads (Life Technologies) in buffer
comprising 50 mM Tris-HCl pH 9.5, 150 mM NaCl, 2 mM CaCl2, 0.05% (v/v)
Tween-20, and 1% (w/v) BSA (Sigma-Aldrich). Washed beads were then
incubated with 15 mg His-tagged protein in the same buffer, but at pH 7.4
instead of pH 9.5, for 1 hr. The beads were then washed with 50 mM Tris-HCl
pH 7.4, 150 mM NaCl, 0.05% (v/v) Tween-20, and boiled in reducing
SDS-PAGE sample buffer. Samples were analyzed by SDS-PAGE andwestern
blotting. His-tagged protein was detected using an anti-RGS-His-horseradish
peroxidase (HRP) conjugated antibody (QIAGEN) and biotinylated protein was
detected using streptavidin-peroxidase (Sigma-Aldrich). Jagged-1 DSL-EGF3
control protein was kindly provided by Dr. Chandramouli Chillakuri.
NMR Spectroscopy
The NMR experiments used for resonance assignment and data processing
were described previously (Yadin et al., 2012). For the results described
here, spectra were acquired using in-house-built spectrometers with Oxford
Instrument magnets, GE/Omega consoles, and 1H operating frequencies of
600 or 750 MHz. NMR experiments for structure determination and dynamics
studies were carried out using 15N- or 13C/15N-labeled FUN-EGF3 at a con-
centration of 1.5 mM at pH 5.4 and 298 K. Three-dimensional (3D) 15N-edited
and 13C-edited NOE spectroscopy (NOESY)-heteronuclear single-quantum
correlation spectroscopy (HSQC) spectra (mixing times 75 and 150 ms)
were acquired at 750 MHz for FUN-EGF3 in 5% D2O/95% H2O (v/v) and
100% D2O, respectively.
1H-15N RDCs were measured using a bicelle align-
ment medium at 308 K. 15N relaxation experiments were performed at 600
MHz. Heteronuclear NOE ratios and longitudinal (T1) and transverse (T2) relax-
ation times were measured using established pulse sequences as described
previously (Kay et al., 1989a).
Structure Determination
Distance restraints for structure calculation were derived from 3D 15N-edited
and 13C-edited NOESY spectra (mixing time 75 ms). Cross-peaks were
assigned manually using published resonance assignments (Yadin et al.,
2012). The f angle restraints for some residues were obtained using 3JHNHa
values from a heteronuclear multiple-quantum correlation spectroscopy
(HMQC)-J experiment (Kay et al., 1989b). Restraints of 120 ± 40 were
used for residueswith 3JHNHa> 8Hz. Additionalf andc torsion angle restraints
were obtained using TALOS+ predictions on the basis of assigned chemical
shifts (Shen et al., 2009). Simulated annealing and refinement calculations
were performed using Xplor-NIH 2.29 (Schwieters et al., 2006). Structures
were refined with a Rama torsion angle database potential (Kuszewski et al.,
1996), a potential of mean force for hydrogen bond donor-acceptor pairs
(Grishaev and Bax, 2004), and RDCs. The axial and rhombic components for1754 Structure 21, 1743–1756, October 8, 2013 ª2013 The Authorsthe alignment tensors (separate values used for FUN-EGF1 and EGF2-
EGF3) were calculated from partially refined structures using in-house-
developed software. Ramachandran validation statistics were calculated
using Procheck (Laskowski et al., 1996).
Analysis of Dynamics Data
T1 and T2 values were obtained by fitting single exponential decays to peak
intensities measured with 12 different delay times. Heteronuclear NOE ratios
were calculated from the peak intensities of spectra with and without 1H
presaturation. Errors were estimated using 500 Monte Carlo simulations,
with the baseline noise as a measure of peak height error, as described
previously (Bruylants and Redfield, 2009).
For further details regarding the materials and methods used in this work,
see Supplemental Experimental Procedures.ACCESSION NUMBERS
The atomic coordinates of the FUN-EGF3 ensemble and structure calculation
restraints have been deposited in the Protein Data Bank under accession
number 2M74.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2013.08.004.
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